Chuangzhou Rao Liangqin Nie Xiaokang Wu Xiaobo Miao Ting Chen Liuxi Chen Dongqing Zhang Quan Lin
10.3389/fonc.2022.915502
Front Oncol
2022 Sep 20;12:915502.
alk c1156 acquired resistance alectinib crizotinib non-small cell lung cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/36203454/
Case Reports
PMC9530790
36203454
Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation
2022